Safety and Feasibility of HIPEC for High-Risk Gallbladder Adenocarcinoma
Safety and Feasibility of Prophylactic Heated Intra-peritoneal Chemotherapy (HIPEC) for High-Risk Gallbladder Adenocarcinoma
Sponsor: West Virginia University
Listed as NCT05430035, this EARLY_PHASE1 trial focuses on Gallbladder Adenocarcinoma and remains actively recruiting participants. Sponsored by West Virginia University, it has been updated 6 times since 2022, reflecting limited change activity. This study contributes to the evolving evidence base for cancer treatment protocols.
Status Flow
Change History
6 versions recorded-
Mar 2025 — Present [monthly]
Recruiting EARLY_PHASE1
-
Sep 2024 — Mar 2025 [monthly]
Recruiting EARLY_PHASE1
-
Jul 2024 — Sep 2024 [monthly]
Recruiting EARLY_PHASE1
-
Feb 2024 — Jul 2024 [monthly]
Recruiting EARLY_PHASE1
-
Nov 2022 — Feb 2024 [monthly]
Recruiting EARLY_PHASE1
Status: Not Yet Recruiting → Recruiting
▶ Show 1 earlier version
-
Jul 2022 — Nov 2022 [monthly]
Not Yet Recruiting EARLY_PHASE1
First recorded
Jun 2022
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- West Virginia University
For direct contact, visit the study record on ClinicalTrials.gov .